These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8586406)

  • 1. [The use of measuring serum soluble IL-2 receptor levels in cyclosporine-A treated lupus nephritis].
    Zheng X; Lin M; Cui X; Yao Q; Zhou G; Guo Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Sep; 26(3):338-41. PubMed ID: 8586406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis.
    Tang Z; Zhang J; Zhang S; Li L
    Chin Med J (Engl); 1997 Sep; 110(9):686-9. PubMed ID: 9642325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble interleukin-2 receptor levels in lupus nephritis.
    Laut J; Senitzer D; Petrucci R; Sablay LB; Barland P; Glicklich D
    Clin Nephrol; 1992 Oct; 38(4):179-84. PubMed ID: 1424303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative clinical prospective therapeutic study between cyclophosphamide, cyclosporine and azathioprine in the treatment of lupus nephritis.
    El-Sehemy MS; Al-Saaran AM; Baddour NM; Adam AG; Moez PE
    Egypt J Immunol; 2006; 13(1):39-52. PubMed ID: 17974149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose.
    Tanaka H; Oki E; Tsuruga K; Yashiro T; Hanada I; Ito E
    Clin Nephrol; 2009 Dec; 72(6):430-6. PubMed ID: 19954719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urine levels of soluble interleukin 2 receptor and free light chain immunoglobulins in lupus nephritis].
    Ling SH
    Zhonghua Yi Xue Za Zhi; 1993 Dec; 73(12):756-8, 774. PubMed ID: 8143195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D
    Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neopterin and a soluble interleukin-2 receptor in patients with systemic lupus erythematodes].
    Horák P; Hermanová Z; Ordeltová M; Faltýnek L; Kusá L; Budíková M; Vavrdová V; Opíchalová D; Ciferská H; Scudla V
    Vnitr Lek; 2004 Jun; 50(6):422-7. PubMed ID: 15346634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis.
    Hung WT; Chen YM; Lan JL; Chen HH; Chen YH; Chen DY; Hsieh CW; Wen MC
    Lupus; 2011 Nov; 20(13):1404-10. PubMed ID: 21946514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of lupus nephritis with cyclosporine - an outcome analysis.
    Rihova Z; Vankova Z; Maixnerova D; Dostal C; Jancova E; Honsova E; Merta M; Rysava R; Tesar V
    Kidney Blood Press Res; 2007; 30(2):124-8. PubMed ID: 17396037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulated MHC-class II expression and gamma-IFN and soluble IL-2R in lupus nephritis.
    Yokoyama H; Takabatake T; Takaeda M; Wada T; Naito T; Ikeda K; Goshima S; Takasawa K; Tomosugi N; Kobayashi K
    Kidney Int; 1992 Sep; 42(3):755-63. PubMed ID: 1405353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of low-dose cyclosporine A in the treatment of refractory proteinuria in childhood-onset lupus nephritis.
    Baca V; Catalán T; Villasís-Keever M; Ramón G; Morales AM; Rodríguez-Leyva F
    Lupus; 2006; 15(8):490-5. PubMed ID: 16942000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum level of proximal renal tubular epithelial cell-binding immunoglobulin G in patients with lupus nephritis.
    Yap DY; Yung S; Zhang Q; Tang C; Chan TM
    Lupus; 2016 Jan; 25(1):46-53. PubMed ID: 26251400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease.
    Brugos B; Kiss E; Dul C; Gubisch W; Szegedi G; Sipka S; Zeher M
    Hum Immunol; 2010 Sep; 71(9):874-7. PubMed ID: 20538031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of serum C3 and CH50 levels as markers of disease-activity and indicators of efficacy of treatment of lupus nephritis in childhood].
    Ibe M; Kuriyama T; Mori M; Mitsuda T; Aihara Y; Yokota S
    Ryumachi; 1994 Aug; 34(4):715-24. PubMed ID: 7974022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus.
    Ishizaki J; Saito K; Nawata M; Mizuno Y; Tokunaga M; Sawamukai N; Tamura M; Hirata S; Yamaoka K; Hasegawa H; Tanaka Y
    Rheumatology (Oxford); 2015 Mar; 54(3):405-12. PubMed ID: 25183834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of cyclosporin a neoral in the treatment of paediatric lupus nephritis with heavy proteinuria.
    Fu LW; Yang LY; Chen WP; Lin CY
    Br J Rheumatol; 1998 Feb; 37(2):217-21. PubMed ID: 9569080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
    Tesar V; Jirsa M; Masek Z; Bartůnková J; Stejskalová A; Dostál C; Zabka J; Chábová V; Rysavá R
    Cas Lek Cesk; 1998 May; 137(9):271-5. PubMed ID: 9650355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.